Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP632329.RAnSxjFAq4b6aeDo5Y6UPv7lCanFXRxyZAOS31Iz4JjFg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP632329.RAnSxjFAq4b6aeDo5Y6UPv7lCanFXRxyZAOS31Iz4JjFg130_assertion type Assertion NP632329.RAnSxjFAq4b6aeDo5Y6UPv7lCanFXRxyZAOS31Iz4JjFg130_head.
- NP632329.RAnSxjFAq4b6aeDo5Y6UPv7lCanFXRxyZAOS31Iz4JjFg130_assertion wasGeneratedBy ECO_0000203 NP632329.RAnSxjFAq4b6aeDo5Y6UPv7lCanFXRxyZAOS31Iz4JjFg130_provenance.
- NP632329.RAnSxjFAq4b6aeDo5Y6UPv7lCanFXRxyZAOS31Iz4JjFg130_assertion wasDerivedFrom befree-20140225 NP632329.RAnSxjFAq4b6aeDo5Y6UPv7lCanFXRxyZAOS31Iz4JjFg130_provenance.
- NP632329.RAnSxjFAq4b6aeDo5Y6UPv7lCanFXRxyZAOS31Iz4JjFg130_assertion SIO_000772 14965315 NP632329.RAnSxjFAq4b6aeDo5Y6UPv7lCanFXRxyZAOS31Iz4JjFg130_provenance.
- NP632329.RAnSxjFAq4b6aeDo5Y6UPv7lCanFXRxyZAOS31Iz4JjFg130_assertion evidence source_evidence_literature NP632329.RAnSxjFAq4b6aeDo5Y6UPv7lCanFXRxyZAOS31Iz4JjFg130_provenance.
- NP632329.RAnSxjFAq4b6aeDo5Y6UPv7lCanFXRxyZAOS31Iz4JjFg130_assertion description "[Furthermore the identification of genetic polymorphisms in the effectors involved in the pathophysiology of hypertension or in the response to anti-hypertensive drugs, such as the p22phox subunit of NADPH oxidase, alpha-adducin or adrenergic receptors, has promoted the prospective of both better understanding of hypertension and individualized strategies for its treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP632329.RAnSxjFAq4b6aeDo5Y6UPv7lCanFXRxyZAOS31Iz4JjFg130_provenance.